ONCY Share Price

Open 0.36 Change Price %
High 0.36 1 Day -0.02 -5.71
Low 0.31 1 Week 0.00 0.00
Close 0.33 1 Month 0.00 0.00
Volume 802355 1 Year 0.00 0.00
52 Week High 9.36
52 Week Low 0.00
ONCY Important Levels
Resistance 2 0.38
Resistance 1 0.36
Pivot 0.33
Support 1 0.30
Support 2 0.28
NASDAQ USA Most Active Stocks
SIRI 4.30 -5.49%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
QQQ 115.67 0.17%
WRES 0.09 0.00%
More..
NASDAQ USA Top Gainers Stocks
QKLS 0.21 110.00%
LOCM 0.09 50.00%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
PERF 1.90 22.58%
ASNA 7.01 20.24%
SBSA 4.60 17.95%
CEMP 7.55 15.27%
XXIA 15.55 14.76%
More..
NASDAQ USA Top Losers Stocks
PTIX 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
AMCF 0.03 -50.00%
OPXAW 0.01 -50.00%
VALV 0.03 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
More..

Oncolytics Biotech, Inc. (NASDAQ: ONCY)

ONCY Technical Analysis 5
As on 4th Nov 2015 ONCY Share Price closed @ 0.33 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.60 & Strong Sell for SHORT-TERM with Stoploss of 0.49 we also expect STOCK to react on Following IMPORTANT LEVELS.
ONCY Target for December
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
Oncolytics Biotech, Inc. ( NASDAQ USA Symbol : ONCY )
Sector : N/AIndustry:N/AFull Time Employees:N/ABusiness Summary Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancers. The company develops REOL And Other Stocks in Same Sector
ONCY
0.33 -0.02 (-5.71 %)
LT : Strong Sell
ST : Strong Sell
ONCY Other Details
Segment EQ
Market Capital 153322176.00
Sector N/AIndustry:N/AFull Time Employees:N/ABusiness Summary Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancers. The company develops REOL
Industry N/AFull Time Employees:N/ABusiness Summary Oncolytics Biotech Inc., a development stage biophar
Offical website http://www.oncolyticsbiotech.com
ONCY Address
ONCY
1167 Kensington Crescent NW
Suite 210
Calgary, AB T2N 1X7
Canada
Phone: 403-670-7377
Fax: 403-283-0858
Interactive Technical Analysis Chart Oncolytics Biotech, Inc. ( ONCY NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Oncolytics Biotech, Inc.
ONCY Business Profile
Oncolytics Biotech Inc. (Oncolytics) is a development-stage company. The Company is focused on its research and development of REOLYSIN, which is its cancer therapeutic. REOLYSIN is developed from the reovirus. This virus has been demonstrated in tumour cells bearing an activated Ras pathway. Oncolytics is directing a clinical trial program with the focus of developing REOLYSIN as a human cancer therapeutic. The clinical program includes clinical trials, which it sponsors directly along with Third Party Clinical Trials. Third Party Clinical Trials are clinical trials that are being sponsored by other institutions. As of December 31, 2011, the United States National Cancer Institute (NCI), the University of Leeds and the Cancer Therapy & Research Center at the University of Texas Health Center in San Antonio (CTRC) were sponsoring part of its clinical trial program. Oncolytics uses contract toll manufacturers to produce REOLYSIN.